Search Results

November 2021 Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc today announced that Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has successfully completed Phase 1 studies in Japan with JNJ-40411813 (ADX71149).

Anthony Johnson as President/CEO! Save the dates: February 8 - 29: Join Dr.

Elizabeth Johnstone were awarded one of the 2022 Diabetes Research Grants at the World Diabetes Day Breakfast "Congratulations to Perkins Professor Kevin Pfleger and Dr Elizabeth Johnstone who were awarded one of

Previous companies worked at include OrthoBiotech (OBI), a division of Johnson & Johnson and GlaxoSmithKline

Announcements Please save the date for the 2024 aGPCR workshop hosted by Antony Boucard! Member Profile Antony Boucard Professor Centro de Investigación y de Estudios Avanzados del IPN (Cinvestav

Antony Boucard's research on "Biased Signaling is Structurally Encoded As An Autoproteolysis Event in

.; Johnstone, E. K. M.; Wheal, A. J.; Goulding, J.; Robers, M. B.; Machleidt, T.; Wood, K.

stability of the salt bridge depends on the position of NH2, which is most stable at position 1 (Wasilko, Johnson

.; Johnsson, K. doi.org/10.1038/nmeth.1213 . (23)      Keppler, A.; Gendreizig, S.; Gronemeyer, T.; Pick, H.; Vogel, H.; Johnsson